News

T cells can sense testosterone—What does that mean for prostate cancer therapies?
The future is bright for prostate cancer research. It's glowing, in fact, thanks to new tools that combine the eye-catching ...
The New England Journal of Medicine24d
Tumor-Infiltrating Clonal Hematopoiesis
The frequency of TI-CH and its effect on tumor evolution are unclear. We characterized CHIP and TI-CH in 421 patients with early-stage non–small-cell lung cancer (NSCLC) from the TRACERx study ...
Science Daily18h
Enzyme identified as an important tumor inhibitor in T-cell lymphomas
Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system. Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of ...
Science Daily22d
New cell therapy shows promising results in advanced tumor diseases
In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors ...
Enzyme HDAC1 found to suppress tumor growth in aggressive T-cell lymphomas
Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system ...
Hosted on MSN22d
Novel cell therapy shows promising results in advanced tumor diseases
In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors ...